PeptidePedia The community reference

Contributions of GreyMarketGreer

User contributions·18 logged edits·page 1 of 1

Contributions by GreyMarketGreer, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,733 edits includes activity predating the current log.

  1. 10:20, 19 Jun 2026 (diff | hist) Talk:Patent expiry and biosimilars 537 +147 /* Expiry does not change research supply */ new section
  2. 06:15, 13 Jun 2026 (diff | hist) GLP-1 receptor 7,570 ±0 correct the direction of the effect on gastric emptying
  3. 13:50, 5 Jun 2026 (diff | hist) Talk:Regulatory status by jurisdiction 748 +89 /* Presentation test */ reply
  4. 09:40, 30 Mar 2026 (diff | hist) Talk:Grey market 400 +184 /* Is the term useful here at all? */ new section
  5. 10:59, 10 Feb 2026 (diff | hist) ISO 9001 4,278 ±0 expand §What the standard requires
  6. 08:59, 4 Dec 2025 (diff | hist) Insulin secretion 6,940 ±0 typo
  7. 22:05, 2 Dec 2025 (diff | hist) Research use only 7,990 ±0 m fix a dangling clause
  8. 15:47, 11 Nov 2025 (diff | hist) Talk:Vial 885 +370 /* The unmarked-vial paragraph is close to describing evasion */ reply
  9. 10:30, 4 Nov 2025 (diff | hist) Customs seizure 4,785 ±0 add the jurisdiction to the legal statement
  10. 21:36, 24 Sep 2025 (diff | hist) WuXi TIDES 16,214 +1,570 serial comma per PP:MOS
  11. 17:28, 17 Aug 2025 (diff | hist) Active pharmaceutical ingredient 4,355 ±0 expand §The regulatory frame
  12. 06:24, 5 Aug 2025 (diff | hist) Research use only 7,724 ±0 add the note that a certificate of analysis has no regulatory standing
  13. 08:34, 28 Apr 2025 (diff | hist) Customs seizure 3,644 ±0 m rm the speculation about future scheduling
  14. 16:46, 25 Feb 2025 (diff | hist) Good manufacturing practice 3,548 ±0 m add the pharmacopoeial chapter reference
  15. 19:34, 5 Jan 2025 (diff | hist) Drug master file 2,228 ±0 state that the position differs between jurisdictions and give two examples
  16. 17:16, 3 Jan 2025 (diff | hist) Good manufacturing practice 2,538 +37 de-orphan
  17. 12:31, 13 Dec 2024 (diff | hist) Active pharmaceutical ingredient 1,752 ±0 rm the advice on importation; the article describes the position and does not advise
  18. 09:35, 21 Nov 2024 (diff | hist) Regulatory status by jurisdiction 2,139 ±0 clarify that a business licence is not a manufacturing authorisation